Drug Delivery by Electroporation: Review

Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Most common routes of administration include the preferred non-invasive peroral (through the mouth), topical (skin), transmucosal (nasal, buccal/sublingual, vaginal, ocular and rectal) and inhalation routes. Current effort in the area of drug delivery include the development of targeted delivery in which the drug is only active in the target area of the body (for example, in cancerous tissues) and sustained release formulations in which the drug is released over a period of time in a controlled manner from a formulation. This is achieved by combining electroporation with the input of drugs at a location. This paper reviews the process of electroporation and then further discusses the electrochemotherapy, one of the most upcoming application of electroporation in biotechnology.

[1]  M. Čemažar,et al.  Effective treatment of perianal tumors in dogs with electrochemotherapy. , 2005, Anticancer research.

[2]  D. Dimitrov.  Chapter 18 - Electroporation and Electrofusion of Membranes , 1995 .

[3]  L. Chernomordik,et al.  Reversible electrical breakdown of lipid bilayers: formation and evolution of pores. , 1988, Biochimica et biophysica acta.

[4]  Richard Heller,et al.  Electrochemotherapy, electrogenetherapy, and transdermal drug delivery : electrically mediated delivery of molecules to cells , 2000 .

[5]  Richard Heller,et al.  Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery , 2000 .

[6]  S. Lippman,et al.  Potential of retinoids in cancer prevention. , 1994, Cancer treatment reviews.

[7]  U. Zimmermann,et al.  Transcellular ion flow in Escherichia coli B and electrical sizing of bacterias. , 1973, Biophysical journal.

[8]  Wanda Krassowska,et al.  Asymptotic model of electroporation , 1999 .

[9]  Damijan Miklavčič,et al.  Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy , 1995 .

[10]  Julie Gehl,et al.  Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. , 2003, Cancer treatment reviews.

[11]  H. Itoh,et al.  Time courses of cell electroporation as revealed by submicrosecond imaging of transmembrane potential. , 1993, Biophysical journal.

[12]  E. Neumann,et al.  The Relaxation Hysteresis of Membrane Electroporation , 1989 .

[13]  C. Nicolau,et al.  20 – Electroinsertion: An Electrical Method for Protein Implantation into Cell Membranes , 1991 .

[14]  M. Čemažar,et al.  Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. , 2005, Anti-cancer drugs.

[15]  M. R. Tarasevich,et al.  246 - Electric breakdown of bilayer lipid membranes I. The main experimental facts and their qualitative discussion , 1979 .

[16]  K. Rosenheck,et al.  Effect of electric fields on light-scattering and fluorescence of chromaffin granules , 1975, The Journal of Membrane Biology.

[17]  J. Weaver,et al.  Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Serša,et al.  Electrochemotherapy : animal model work review. , 2000, Methods in molecular medicine.

[19]  Damijan Miklavčič,et al.  Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice , 1996 .

[20]  M. Čemažar,et al.  Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice , 2005, BMC Cancer.

[21]  V. Préat,et al.  Transdermal Delivery of Metoprolol by Electroporation , 1994, Pharmaceutical Research.

[22]  R. Orentas,et al.  Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine. , 2001, Cellular immunology.

[23]  L. Mir,et al.  Antimetastatic effects of electrochemotherapy and of histoincompatible interleukin‐2-secreting cells in the murine Lewis lung tumor , 1998, Anti-cancer drugs.

[24]  E. Neumann,et al.  Permeability changes induced by electric impulses in vesicular membranes , 1972, The Journal of Membrane Biology.

[25]  Hiroyasu Itoh,et al.  3 – Events of Membrane Electroporation Visualized on a Time Scale from Microsecond to Seconds , 2012 .

[26]  T. Tsong,et al.  Formation and resealing of pores of controlled sizes in human erythrocyte membrane , 1977, Nature.

[27]  J. Vienken,et al.  Development of drug carrier systems: Electrical field induced effects in cell membranes* , 1980 .

[28]  Julie Gehl,et al.  Electroporation for drug and gene delivery in the clinic: doctors go electric. , 2008, Methods in molecular biology.

[29]  J. Weaver,et al.  Electroporation: A general phenomenon for manipulating cells and tissues , 1993, Journal of cellular biochemistry.

[30]  D. Banerjee,et al.  Hematopoietic stem cell gene therapy with drug resistance genes: an update , 2005, Cancer Gene Therapy.

[31]  Serša Gregor.  Electrochemotherapy in treatment of solid tumours in cancer patients , 2007 .

[32]  S. Orlowski,et al.  Electrochemotherapy on liver tumours in rabbits. , 1998, British Journal of Cancer.

[33]  S. Novaković,et al.  Potentiation of bleomycin antitumor effectiveness by electrotherapy. , 1993, Cancer letters.

[34]  Damijan Miklavčič,et al.  Time course of transmembrane voltage induced by time-varying electric fields—a method for theoretical analysis and its application , 1998 .

[35]  D. Chang,et al.  Guide to Electroporation and Electrofusion , 1991 .

[36]  U. Zimmermann,et al.  CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion. , 2001, Journal of immunological methods.

[37]  B Deuticke,et al.  Formation and properties of aqueous leaks induced in human erythrocytes by electrical breakdown. , 1985, Biochimica et biophysica acta.

[38]  W. Goebel,et al.  Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice , 2005, BMC Cancer.

[39]  T. Tsong,et al.  Voltage-induced pore formation and hemolysis of human erythrocytes. , 1977, Biochimica et biophysica acta.

[40]  A. Dalgleish,et al.  Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines. , 2000, Biochimica et biophysica acta.

[41]  D. Miklavčič,et al.  Intrinsic Sensitivity of Tumor Cells to Bleomycin as an Indicator of Tumor Response to Electrochemotherapy , 1998, Japanese journal of cancer research : Gann.

[42]  L. Mir,et al.  Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. , 1991, European journal of cancer.

[43]  D Miklavcic,et al.  Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. , 1995, Cancer research.

[44]  M. Jaroszeski,et al.  Bleomycin-mediated electrochemotherapy of basal cell carcinoma. , 1996, Journal of the American Academy of Dermatology.

[45]  P. Gaynor,et al.  Couplet alignment and improved electrofusion by dielectrophoresis for a zona-free high-throughput cloned embryo production system , 2006, Medical and Biological Engineering and Computing.

[46]  L. Chernomordik,et al.  Breakdown of lipid bilayer membranes in an electric field , 1983 .

[47]  T. Reese,et al.  Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy. , 1990, Biophysical journal.

[48]  D Miklavcic,et al.  Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases , 2000, Melanoma research.

[49]  U. Zimmermann,et al.  Electric field-mediated fusion and related electrical phenomena. , 1982, Biochimica et biophysica acta.